| Literature DB >> 34354264 |
Ximing Shao1,2, Zhihao Ding1,2, Wenhua Zhou1, Yanyan Li1,3, Zhibin Li1, Haodong Cui1, Xian Lin1, Guoli Cao1, Binghua Cheng1,3, Haiyan Sun1, Meiqing Li1,3, Ke Liu1,2, Danyi Lu1, Shengyong Geng1, Wenli Shi1,4, Guofang Zhang1, Qingle Song1, Liang Chen1, Guocheng Wang1, Wu Su1, Lintao Cai1,2, Lijing Fang1, David Tai Leong5, Yang Li6, Xue-Feng Yu7, Hongchang Li8,9,10.
Abstract
Although nanomaterials have shown promising biomedical application potential, incomplete understanding of their molecular interactions with biological systems prevents their inclusion into mainstream clinical applications. Here we show that black phosphorus (BP) nanomaterials directly affect the cell cycle's centrosome machinery. BP destabilizes mitotic centrosomes by attenuating the cohesion of pericentriolar material and consequently leads to centrosome fragmentation within mitosis. As a result, BP-treated cells exhibit multipolar spindles and mitotic delay, and ultimately undergo apoptosis. Mechanistically, BP compromises centrosome integrity by deactivating the centrosome kinase polo-like kinase 1 (PLK1). BP directly binds to PLK1, inducing its aggregation, decreasing its cytosolic mobility and eventually restricting its recruitment to centrosomes for activation. With this mechanism, BP nanomaterials show great anticancer potential in tumour xenografted mice. Together, our study reveals a molecular mechanism for the tumoricidal properties of BP and proposes a direction for biomedical application of nanomaterials by exploring their intrinsic bioactivities.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34354264 DOI: 10.1038/s41565-021-00952-x
Source DB: PubMed Journal: Nat Nanotechnol ISSN: 1748-3387 Impact factor: 39.213